blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2021017

EP2021017 - VACCINATION AGAINST CANCER [Right-click to bookmark this link]
Former [2009/07]METHOD
[2009/15]
StatusThe application is deemed to be withdrawn
Status updated on  31.12.2010
Database last updated on 07.10.2024
Most recent event   Tooltip31.12.2010Application deemed to be withdrawnpublished on 02.02.2011  [2011/05]
Applicant(s)For all designated states
GlaxoSmithKline Biologicals s.a.
rue de l'Institut 89
1330 Rixensart Brussels / BE
[2009/07]
Inventor(s)01 / BRICHARD, Vincent
GlaxoSmithKline Biologicals sa rue de l'Institut 89
B-1330 Rixensart / BE
02 / LEHMANN, Frederic Francois Eugene
GlaxoSmithKline Biologicals sa rue de l'Institut 89
B-1330 Rixensart / BE
 [2009/07]
Representative(s)Lovatt, Victoria Jayne, et al
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [2009/07]Lovatt, Victoria Jayne, et al
GlaxoSmithKline, Corporate Intellectual Property CN925.1, 980 Great West Road Brentford
Middlesex TW8 9GS / GB
Application number, filing date07729468.424.05.2007
[2009/07]
WO2007EP55037
Priority number, dateGB2006001054726.05.2006         Original published format: GB 0610547
GB2007000730716.04.2007         Original published format: GB 0707307
[2009/07]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007137986
Date:06.12.2007
Language:EN
[2007/49]
Type: A2 Application without search report 
No.:EP2021017
Date:11.02.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 06.12.2007 takes the place of the publication of the European patent application.
[2009/07]
Search report(s)International search report - published on:EP31.01.2008
ClassificationIPC:A61K39/00, C07K14/47
[2009/07]
CPC:
A61P35/00 (EP); A61K39/001186 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/07]
Extension statesALNot yet paid
BANot yet paid
HR14.11.2008
MKNot yet paid
RSNot yet paid
TitleGerman:IMPFUNG GEGEN KREPS[2009/15]
English:VACCINATION AGAINST CANCER[2009/15]
French:VACCIN CONTRE LE CANCER[2009/15]
Former [2009/07]VERFAHREN
Former [2009/07]METHOD
Former [2009/07]MÉTHODE
Entry into regional phase14.11.2008National basic fee paid 
14.11.2008Designation fee(s) paid 
14.11.2008Examination fee paid 
Examination procedure14.11.2008Examination requested  [2009/07]
17.04.2009Despatch of a communication from the examining division (Time limit: M06)
15.10.2009Reply to a communication from the examining division
01.02.2010Despatch of a communication from the examining division (Time limit: M06)
12.08.2010Application deemed to be withdrawn, date of legal effect  [2011/05]
17.09.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2011/05]
Fees paidRenewal fee
07.05.2009Renewal fee patent year 03
31.03.2010Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2005105139  (GLAXOSMITHKLINE BIOLOG SA [BE], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.